Psychedelics Archives

Model legislation would authorize groundbreaking research into ibogaine for mental health

Backgrounder by Aubri Strachan, Geoffrey Lawrence and Leonard Gilroy

Ibogaine could transform public spending on opioid treatment

Backgrounder by Madison Carlino

FAQ: Timeline for FDA ibogaine approval

FAQ by Gregory Ferenstein

Ibogaine and veterans’ mental health

Backgrounder by Aubri Strachan

Ibogaine offers breakthrough treatment for mental health, addiction, and TBIs

Backgrounder by Aubri Strachan

Ibogaine offers major promise in treating addiction, mental health

Backgrounder by Madison Carlino and Leonard Gilroy

Legalizing psilocybin access in Arizona would benefit mental health

Backgrounder by Leonard Gilroy and Geoffrey Lawrence

Psychedelic treatment for neurodegenerative disorders

Policy Brief by Madison Carlino

Psychedelic drug policy recommendations for the incoming Trump administration

Backgrounder by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein

Ibogaine treatment for opioid use disorder

Policy Brief by Madison Carlino

Regulated psilocybin access in Arizona would help treat mental health conditions

Backgrounder by Leonard Gilroy and Geoffrey Lawrence

A policy framework for personal psychedelics licenses

Policy Brief by Gregory Ferenstein

Modernizing psilocybin policy to improve mental health outcomes

Policy Brief by Madison Carlino